-transparent.png){kind=logo}
Migration of vascular smooth muscle cells (VSMCs) is a crucial response to vascular injury resulting in neointima formation and atherosclerosis. Platelet-derived growth factor (PDGF-BB) functions as a potent chemoattractant for VSMCs and enhances these pathologies in the vasculature. However, little is known about the intracellular pathways that mediate VSMC migration. In the present study, we investigated the role of mitogen-activated protein kinase (MAPK) activation in this function, since PDGF-BB as well as other growth factors activate this pathway. Using an in-gel kinase assay, we observed that PD 98059 an inhibitor of MEK that activates MAP kinase, inhibited PDGF-BB-induced activation of ERK-1 and ERK-2 in cultured rat aortic smooth muscle cells in a concentration-dependent manner. In contrast, PDGF-mediated activation of intracellular calcium release was not affected by PD 98059. The chemotactic response of both rat aortic smooth muscle cells (RASMCs) and human umbilical vein smooth muscle cells (HUSMCs) toward PDGF-BB (10 ng/mL) was significantly reduced by PD 98059 (10 mumol/L) to 41.7 +/- 7.1% in RASMCs (P < .01) and to 47.2 +/- 5.3% in HUSMCs (P < .01). Similar inhibition was seen at 30 mumol/L, less at 1 mumol/L. To further confirm the specificity of these results implicating the MAPK pathway, an antisense oligodeoxynucleotide (ODN) directed against the initiation translation site of rat ERK-1 and ERK-2 mRNA was used to suppress MAP kinase synthesis and function in rat VSMCs. Liposomal transfection with 0.4 mumol/L antisense ODN reduced ERK-1 and ERK-2 protein by 65% (P < .01) after 48 hours. The chemotactic response to PDGF-BB (10 ng/mL) was reduced by 75% (P < .01) in rat VSMCs transfected with the same antisense ODN concentration. Sense and scrambled control ODNs (0.4 mumol/L) did not affect ERK-1 and ERK-2 protein concentrations or chemotaxis of VSMCs induced by PDGF-BB. These experiments provide the first evidence that activation of MAPK is a critical event in PDGF-mediated signal transduction regulating VSMC migration.
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
August 2001,
European journal of clinical investigation,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
November 2007,
Hypertension research : official journal of the Japanese Society of Hypertension,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
August 2001,
Endocrine journal,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
November 1993,
Proceedings of the National Academy of Sciences of the United States of America,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
December 2004,
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
February 2013,
Archives of biochemistry and biophysics,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
February 2003,
Journal of pharmacological sciences,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
March 2002,
Experimental & molecular medicine,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
January 1996,
The Journal of biological chemistry,
K Graf, and
X P Xi, and
D Yang, and
E Fleck, and
W A Hsueh, and
R E Law
January 1997,
Cellular signalling,
